There is no cause greater than the fight for our Children’s right to grow up to be adults.
In 2020, Storm the Heavens Fund donated $10,000 to Oncoceutics, a clinical-stage drug discovery and development company. The donation was to assist in funding an Expanded Access program for ONC201 in the United States. ONC201 is an investigational medicine that is being evaluated in Phase I and Phase II trials.
The program will allow Oncoceutics to work with physicians practicing in the United States to provide ONC201 to patients with H3 K27M-mutant glioma, including DIPG, who meet certain eligibility criteria and who cannot otherwise access ONC201 by participating in an ongoing clinical trial. The Expanded Access program has been made available to select hospitals across the United States,